|
 |
|
|
 |
 |
|
 |
|
Print View Attached Docs: | | Alias Names: | NTD Risk | | Methodology: | Chemiluminescence (CL) | | Edit Date: | 3/13/2009 | | Performed: | Monday-Friday | | Released: | Next day with pathologist's review. | | CPT Code: | 82105 | | Specimen Collection Details | | Collection: | One 7.5 mL serum separator tube (SST). Also acceptable: One 5 mL red top tube. NOTE: Order on OML’s obstetrics requisition or electronically and include the following required information: patient’s date of birth, current weight, due date, dating method (US, LMP), number of fetuses present, patient’s race, if patient requires insulin, if there is a previous child with neural tube defects; and for in vitro fertilization pregnancies, the age of the egg donor. | | Handling: | Allow to clot, centrifuge and separate serum from cells and pour into a plastic vial immediately. . | | Stability: | 8 hours ambient, 7 days refrigerated, or 3 months frozen. | | Standard Volume: | 1 mL serum. | | Minimum Volume: | 0.5 mL serum. | | Transport: | Refrigerated, or frozen, on dry ice. | | Comments: | Optimum time for screening is between 16-18 weeks gestation. NTD RISK can be performed between 15 weeks, 0 days and 21 weeks, 6 days gestation. For Neural Tube Defect Risk only in second trimester. For Down syndrome risk order Down/Neural Tube Defect Quad Marker (41955). | | Rejection Criteria: | Specimen frozen and thawed more than once.
MEDICARE MAY REQUIRE A SIGNED ADVANCE BENEFICIARY NOTICE (ABN) FOR THIS TEST |
|
 |
|
Home | Site Map |
Privacy Practices | Licensure |
Contact Us
| Login
©
2010
PeaceHealth Laboratories, formerly Oregon Medical Laboratories & Northwest Regional Laboratory. All rights reserved.
|